Literature DB >> 17612528

Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

Maria Lucia Valentino1, Ramon Martí, Saba Tadesse, Luis Carlos López, Jose L Manes, Judy Lyzak, Angelika Hahn, Valerio Carelli, Michio Hirano.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disease due to ECGF1 gene mutations causing thymidine phosphorylase (TP) deficiency. Analysis of post-mortem samples of five MNGIE patients and two controls, revealed TP activity in all control tissues, but not in MNGIE samples. Converse to TP activity, thymidine and deoxyuridine were absent in control samples, but present in all tissues of MNGIE patients. Concentrations of both nucleosides in the tissues were generally higher than those observed in plasma of MNGIE patients. Our observations indicate that in the absence of TP activity, tissues accumulate nucleosides, which are excreted into plasma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612528      PMCID: PMC1986782          DOI: 10.1016/j.febslet.2007.06.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

1.  Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE).

Authors:  L D Fairbanks; A M Marinaki; E A Carrey; S R Hammans; J A Duley
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

2.  Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine.

Authors:  Carla Giordano; Mariangela Sebastiani; Giuseppe Plazzi; Claudia Travaglini; Patrizio Sale; Marcello Pinti; Andrea Tancredi; Rocco Liguori; Pasquale Montagna; Marzio Bellan; Maria Lucia Valentino; Andrea Cossarizza; Michio Hirano; Giulia d'Amati; Valerio Carelli
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

3.  Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.

Authors:  I Nishino; A Spinazzola; A Papadimitriou; S Hammans; I Steiner; C D Hahn; A M Connolly; A Verloes; J Guimarães; I Maillard; H Hamano; M A Donati; C E Semrad; J A Russell; A L Andreu; G M Hadjigeorgiou; T H Vu; S Tadesse; T G Nygaard; I Nonaka; I Hirano; E Bonilla; L P Rowland; S DiMauro; M Hirano
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Late-onset MNGIE due to partial loss of thymidine phosphorylase activity.

Authors:  Ramon Martí; Jan J G M Verschuuren; Alan Buchman; Ikuo Hirano; Saba Tadesse; André B P van Kuilenburg; Albert H van Gennip; Ben J H M Poorthuis; Michio Hirano
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

5.  Altered thymidine metabolism due to defects of thymidine phosphorylase.

Authors:  Antonella Spinazzola; Ramon Marti; Ichizo Nishino; Antonio L Andreu; Ali Naini; Saba Tadesse; Ivana Pela; Enrico Zammarchi; M Alice Donati; Juan A Oliver; Michio Hirano
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

6.  Increased muscle nucleoside levels associated with a novel frameshift mutation in the thymidine phosphorylase gene in a Spanish patient with MNGIE.

Authors:  A Blazquez; M A Martín; M C Lara; R Martí; Y Campos; A Cabello; R Garesse; J Bautista; A L Andreu; J Arenas
Journal:  Neuromuscul Disord       Date:  2005-09-28       Impact factor: 4.296

7.  Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine.

Authors:  Eun-Woo Lee; Yurong Lai; Huixia Zhang; Jashvant D Unadkat
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

8.  Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency.

Authors:  Ramon Martí; Yutaka Nishigaki; Michio Hirano
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

Review 9.  Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update.

Authors:  Giuseppe Pizzorno; Deliang Cao; Janine J Leffert; Rosalind L Russell; Dekai Zhang; Robert E Handschumacher
Journal:  Biochim Biophys Acta       Date:  2002-07-18

10.  Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Giovanna Pontarin; Paola Ferraro; Maria L Valentino; Michio Hirano; Peter Reichard; Vera Bianchi
Journal:  J Biol Chem       Date:  2006-06-13       Impact factor: 5.157

View more
  38 in total

1.  Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Caterina Garone; Saba Tadesse; Michio Hirano
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

Review 2.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

Review 3.  Chronic intestinal pseudo-obstruction.

Authors:  Alexandra Antonucci; Lucia Fronzoni; Laura Cogliandro; Rosanna-F Cogliandro; Carla Caputo; Roberto De Giorgio; Francesca Pallotti; Giovanni Barbara; Roberto Corinaldesi; Vincenzo Stanghellini
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

4.  A new thymidine phosphorylase mutation causing elongation of the protein underlies mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Elena Cardaioli; Francesco Sicurelli; Maria Alessandra Carluccio; Gian Nicola Gallus; Paola Da Pozzo; Mauro Mondelli; Maria Antonietta Margollicci; Vanna Micheli; Antonio Federico; Maria Teresa Dotti
Journal:  J Neurol       Date:  2011-06-12       Impact factor: 4.849

5.  Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity.

Authors:  Ramon Martí; Luis C López; Michio Hirano
Journal:  Methods Mol Biol       Date:  2012

Review 6.  Erythrocyte-mediated delivery of recombinant enzymes.

Authors:  Vincenzo Leuzzi; Luigia Rossi; Claudia Gabucci; Francesca Nardecchia; Mauro Magnani
Journal:  J Inherit Metab Dis       Date:  2016-03-30       Impact factor: 4.982

7.  A second MNGIE patient without typical mitochondrial skeletal muscle involvement.

Authors:  Elena Cardaioli; Paola Da Pozzo; Edoardo Malfatti; Carla Battisti; Gian Nicola Gallus; Carmen Gaudiano; Marco Macucci; Alessandro Malandrini; Maria Margollicci; Anna Rubegni; Maria Teresa Dotti; Antonio Federico
Journal:  Neurol Sci       Date:  2010-03-16       Impact factor: 3.307

Review 8.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

9.  Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion.

Authors:  Carla Giordano; Mariangela Sebastiani; Roberto De Giorgio; Claudia Travaglini; Andrea Tancredi; Maria Lucia Valentino; Marzio Bellan; Andrea Cossarizza; Michio Hirano; Giulia d'Amati; Valerio Carelli
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

10.  Transgene expression of Drosophila melanogaster nucleoside kinase reverses mitochondrial thymidine kinase 2 deficiency.

Authors:  Shuba Krishnan; Xiaoshan Zhou; João A Paredes; Raoul V Kuiper; Sophie Curbo; Anna Karlsson
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.